| Name: | Amikacin EP Impurity G |
| Catalogue No. | VL6230007 |
| CAS No. | 50896-99-6 |
| Molecular Formula | C22H43N5O13 |
| Molecular Weight | 585.61 g/mol |
| Status | In-Stock |
| IUPAC Name | 6-O-(3-amino-3-deoxy-α-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-α-D-glucopyranosyl)-1-N-[(2R)-4-amino-2hydroxybutanoyl]-2-deoxy-D-streptamine |
| Description | Amikacin EP Impurity G (CAS No: 50896-99-6) is an impurity produced during the synthesis of Amikacin or BB-K8 that is a semisynthetic, water-soluble, wide-spectrum aminoglycoside antibiotic that is generally given parenterally for the therapy of Gram-negative infections. |
| References | Wang, Jian, et al. “Separation and Characterization of Unknown Impurities in Amikacin Sulfate by HPLC–MS N.” Chromatographia, vol. 78, no. 15-16, May 2015, pp. 1031–39,https://doi.org/10.1007/s10337-015-2909-8.Adams, E., et al. “Analysis of Amikacin by Liquid Chromatography with Pulsed Electrochemical Detection.” Journal of Chromatography A, vol. 819, no. 1-2, Sept. 1998, pp. 93–97,https://doi.org/10.1016/s0021-9673(98)00394-x. |
